Babesiosis is a tick-borne illness that can cause a wide variety of symptoms, making it difficult to diagnose. The number of cases in the U.S. has been rising – particularly concerning given that Babesia can be transmitted immediately following a tick bite or unknowingly through a tainted blood transfusion. Furthermore, this illness can be deadly or cause serious complications in immunocomprised patients.
In the article “An Atypical Case Presentation of Babesiosis,” Allen and colleagues describe a unique patient who contracted Babesiosis but did not exhibit many of the typical Babesia symptoms, such as night sweats, chills, shortness of breath and weight loss.¹ Instead, his symptoms were limited to weakness, fever, tachycardia and leg pain.
CASE REPORT
A 75-year-old man was admitted to the emergency department with generalized weakness that had been ongoing for one week, a fever and tachycardia. He also had mild swelling of his left leg and leg pain, which he described as intermittent stabbing pain in his left thigh.
The man had a past medical history of hypertension and hyperlipidemia. His initial laboratory test results revealed mild anemia, thrombocytopenia, and renal dysfunction. All other testing was normal.
The patient was treated empirically with acetaminophen and intravenous ceftriaxone and vancomycin.
“On the first day of hospitalization, blood parasites were noted to be present on the patient’s complete blood count (CBC),” the authors’ state.
His treatment was switched and he was prescribed a 10-day course of azithromycin and atovaquone for a possible diagnosis of Babesiosis. However, the patient’s condition deteriorated rapidly.
“The patient’s renal function, anemia, thrombocytopenia and mental status progressively worsened and by hospital day 3 the patient was transferred to the Intensive Care Unit.”
He was then treated successfully with a red blood cell exchange and plasma exchange therapy.
“The patient’s kidney function improved, along with his anemia and thrombocytopenia,” the authors’ state. “The percentage of parasitemia had decreased to 1% from a maximum of 22% on Day 1 of admission.”
Subsequently, PCR testing for Babesiosis was positive for Babesia microti.
Authors’ conclude:
“Tick-borne illnesses should be included in the differential even in low-risk populations and non-endemic regions due to the severity of disease complications.”
“When patients present with vague symptoms, it is important to keep a broad differential.”
“In this case, it could have been beneficial to inquire if the patient spent time outdoors or had any pets or other means by which he may have been exposed to a tick.”
Allen D, Getto L (May 10, 2024) An Atypical Case Presentation of Babesiosis. Cureus 16(5): e60036. doi:10.7759/cureus.60036
_______________
**Comment**
Babesia parasitemia load can vary from 1%-80%, but >10% is considered high, and those who have one of the following: severe hemolytic anemia and/or severe pulmonary, renal or hepatic compromise should be considered for exchange transfusion.
Since this poor man had a high level of parasites and was going downhill in a hurry, lowering the parasite load was crucial to his turnaround. Just shows you how quickly these cases can escalate. I’m thankful the authors remind doctors to consider TBIs even in non-endemic regions, although, these are becoming less and less by the day.
DO NOT PASS THIS BY… MAJOR COLLABORATIVE STUDY FINDS ALL RISK AND NO BENEFIT – STUDY SHOWS 100% OF MYOCARDITIS IN KIDS IS FROM COVID19 SHOTS. MEANWHILE, EFFECTIVENESS DATA SHOW NO BENEFIT TO KIDS.
Study Links COVID-19 mRNA Shots, Not Infection to Heart Failure in Children. This MASSIVE study also shows no benefit in reduction of infection.
ACTION ITEM: CONTACT THE FDA AND DEMAND THEY PREVENT ALL CHILDREN FROM GETTING THESE INJECTIONS. LET THEM KNOW – ENOUGH IS ENOUGH.
A groundbreaking study by researchers from Oxford, Leeds, Harvard, and Bristol has confirmed that myocarditis and pericarditis only appear in children and adolescents following COVID-19 vaccination, not after infection. This extensive research analyzed official government data from over 1 million English children and adolescents, comparing vaccinated and unvaccinated subjects aged 5-11 and 12-15.
Key findings include:
All cases of myocarditis and pericarditis during the study period occurred in vaccinated individuals.
Most myocarditis and pericarditis cases were recorded after the first dose of the vaccine.
Hospitalizations related to COVID-19 were extremely rare among children and adolescents.
Over 50% of children who had myocarditis following the shot required hospitalization.
Read the full study here for more detailed insights. (See link for article, study, and to contact the FDA)
_______________
Remember that Aldén et al has been highly censored but critical to understand. Reverse transcription of mRNA, inserting the foreign code into human DNA has been one of the greatest fears during the mass, indiscriminate ‘vaccination’ campaign. Go here to watch Dr. Peter McCullough discuss how getting the Pfizer or Moderna COVID-19 shot may be permanent for the vaccinated and their progeny.
Prenatal Exposure to COVID-19 mRNA Vaccine BNT162b2 Induces Autism-Like Behaviors in Male Neonatal Rats: Insights into WNT and BDNF Signaling Perturbations
Prenatal Exposure to COVID-19 mRNA Vaccine BNT162b2 Induces Autism-Like Behaviors in Male Neonatal Rats: Insights into WNT and BDNF Signaling Perturbations
The COVID-19 pandemic catalyzed the swift development and distribution of mRNA vaccines, including BNT162b2, to address the disease. Concerns have arisen about the potential neurodevelopmental implications of these vaccines, especially in susceptible groups such as pregnant women and their offspring. This study aimed to investigate the gene expression of WNT, brain-derived neurotrophic factor (BDNF) levels, specific cytokines, m-TOR expression, neuropathology, and autism-related neurobehavioral outcomes in a rat model. Pregnant rats received the COVID-19 mRNA BNT162b2 vaccine during gestation. Subsequent evaluations on male and female offspring included autism-like behaviors, neuronal counts, and motor performance. Molecular techniques were applied to quantify WNT and m-TOR gene expressions, BDNF levels, and specific cytokines in brain tissue samples. The findings were then contextualized within the extant literature to identify potential mechanisms. Our findings reveal that the mRNA BNT162b2 vaccine significantly alters WNT gene expression and BDNF levels in both male and female rats, suggesting a profound impact on key neurodevelopmental pathways. Notably, male rats exhibited pronounced autism-like behaviors, characterized by a marked reduction in social interaction and repetitive patterns of behavior. Furthermore, there was a substantial decrease in neuronal counts in critical brain regions, indicating potential neurodegeneration or altered neurodevelopment. Male rats also demonstrated impaired motor performance, evidenced by reduced coordination and agility. Our research provides insights into the effects of the COVID-19 mRNA BNT162b2 vaccine on WNT gene expression, BDNF levels, and certain neurodevelopmental markers in a rat model. More extensive studies are needed to confirm these observations in humans and to explore the exact mechanisms. A comprehensive understanding of the risks and rewards of COVID-19 vaccination, especially during pregnancy, remains essential.
WHEELCHAIR-BOUND CEO REGAINS ABILITY TO WALK AFTER LYME DISEASE TREATMENT
Lyme arthritis is characterized by joint swelling lasting for weeks to months and potentially causing permanent joint damage. It can worsen symptoms in patients with existing joint conditions such as osteoarthritis and may go undiagnosed, leading to unnecessary surgeries.
In this case report, “Exacerbation of Osteoarthritic Joint Pain by Lyme Disease,” Bennani and colleagues demonstrate the importance in identifying an underlying tick-borne infection, as appropriate treatment can dramatically improve a patient’s quality of life.¹
A 63-year-old man, who was wheelchair-bound, presented to his clinician’s office with severe pain in both knees, which had been progressively worsening over several months. He had previously undergone bilateral knee arthroscopies for meniscal tears and recently received corticosteroid injections, which did not alleviate his pain.
The authors suggest that while corticosteroids can reduce inflammation and alleviate pain, the bacterial infection can continue to proliferate and destroy knee tissue.
“Before treatment, our patient was wheelchair-bound due to the combination of existing osteoarthritis and the manifestation of Lyme disease in his knees.”
“The patient did report that he was recently on erythromycin for an upper respiratory infection (URI) and indicated that his knees felt better while he was taking erythromycin,” the authors state.
Furthermore, the patient, who worked as a chief executive officer (CEO) of a company, was an avid hunter and reported that his dog had Lyme disease.
Given that the patient’s dog had Lyme disease, Lyme IgG and Lyme IgM studies were ordered.
Testing for Lyme disease was positive and the patient began treatment with doxycycline.
“Upon completion of doxycycline therapy, our patient noted significant improvement in his knee pain,” the authors state.
His improvement was so significant that the patient no longer needed the use of a wheelchair and was able to cancel his bilateral knee replacement surgery.
Authors conclude:
“Our patient was able to avoid a costly, high-risk surgical procedure with the detection and treatment of his Lyme disease.”
“Lyme disease should always be a consideration in the differential diagnosis of patients who have lived or have traveled to areas that are endemic to the disease and who tend to have outdoor lifestyles.”
Bennani A Z, Chegwidden B, Lambroussis C G, et al. (April 29, 2024) Exacerbation of Osteoarthritic Joint Pain by Lyme Disease. Cureus 16(4): e59318. doi:10.7759/cureus.59318
_______________
**Comment**
The first thing my mind said to this was duh! Of course the man felt extremely better when being on erythromycin! But, alas, this is where we are in 2024 – after 40 years of mythology about tick-borne illness.
Nothing’s changed.
If you want real help, you must go outside the mainstream medicine (MSM) paradigm, and get to a Lyme literate doctor (LLMD) even though MSM still calls them quacks.
A few important points:
He’s an avid hunter and is outside. This raises the risk for tick-borne infections but you can still get infected in your own backyard.
His dog has Lyme. This happened in our family as well. Dogs are sentinels and a warning shot over the bow. Testing for animals appears to be much better than for people and if your pet is infected – be on guard. Estimates for Lyme based on canine models and human seroprevalence data is far higher than ‘official’ data.
While corticosteroids are loved by doctors for reducing inflammation and pain, they are a double-edged sword for patients who are infected. Since they dampen the immune system they allow infections to worsen which is why identifying underlying infections is imperative.
I’m sorry but by NOW, if a patient improves while on antibiotics, the FIRST thing they should consider is tick-borne infections. I mean really, this nonsense has gone on for far too long.
This man was lucky in that he tested positive. What about the sorry suckers who don’t? I’ll tell you what happens – they are kicked to the curb and allowed to languish for years and years and years until their lives are destroyed and it kills them. Not a very happy ending but it’s happening to thousands upon thousands.
Notice the miraculous turn around of this patient. This often happens – but sometimes it doesn’t because the WRONG treatment is used and it’s a different pathogen to blame. There is nuance to treating this and MSM is woefully uneducated and unprepared. Run away from MSM as fast as you can and get to someone who knows what they are doing. I’m serious. Don’t mess around with this. You will thank me later.
In a recent meta-analysis1,2 posted on preprints.org, Japanese researchers warn of potentially deadly risks to patients who receive blood from people who have taken mRNA covid injections and call for urgent action to ensure the safety of the global blood supply. According to the authors:3
… many countries around the world have reported that so-called genetic vaccines, such as those using modified mRNA encoding the spike protein and lipid nanoparticles as the drug delivery system, have resulted in post-vaccination thrombosis and subsequent cardiovascular damage, as well as a wide variety of diseases involving all organs and systems, including the nervous system …
[B]ased on these circumstances and the volume of evidence that has recently come to light, we call the attention of medical professionals to the various risks associated with blood transfusions using blood products derived from people who have suffered from long covid and from genetic vaccine recipients, including those who have received mRNA vaccines, and we make proposals regarding specific tests, testing methods, and regulations to deal with these risks.
Blood From Injected Donors May Pose Risk to Neurological Health
One particular risk addressed in this paper is the implications of blood tainted with prion-like structures found within the spike protein. Prions are misfolded proteins that can cause neurodegenerative diseases, such as Creutzfeldt-Jakob Disease (“CJD”) in humans, by inducing the misfolding of normal proteins in the brain.
Prion diseases are characterised by a long incubation period, followed by rapid progression and high mortality. The suggestion that the spike protein of SARS-CoV-2, especially from certain variants, might contain prion-like domains raises concerns for several reasons:
Transmission risk – If spike proteins with prion-like structures can be transmitted through blood transfusions, there might be a risk of inducing prion diseases in recipients. Prion diseases are notoriously difficult to diagnose early, have no cure and are fatal, making any potential transmission through blood products a significant safety concern.
Detection and removal challenges – Current blood screening processes do not specifically test for prions, partly because prion diseases are rare and partly due to the technical challenges in detecting prions at low concentrations. If spike proteins with prion-like properties are present in the blood of covid injected people, existing blood safety protocols may not be adequate to prevent transmission.
Long-term safety concerns – Prion diseases have long latency periods, meaning that symptoms can appear years or even decades after exposure. This delay complicates efforts to trace the source of an infection back to a blood transfusion and assess the safety of blood supplies over time.
Impacts on blood supply management – Concerns about the potential risks associated with prion-like structures in spike proteins might lead to changes in donor eligibility criteria or the implementation of additional screening measures. These changes could impact the availability of blood products, which are critical for routine medical procedures.
Public confidence – Public awareness of these potential risks, even if they are theoretical or have a very low likelihood of occurring, could affect people’s willingness to donate or receive blood transfusions, thereby lowering blood donation rates and the overall trust in the safety of blood transfusions.
The authors stress the need for comprehensive studies to better understand the implications of these prion-like structures in the spike protein, not only for mRNA jab safety but also for the broader implications for public health measures like blood transfusion practices.
Other Potential Health Hazards of Contaminated Blood
Contaminated blood may also pose other serious health risks, including:
1. Reduced immune function among blood recipients – It’s been shown that the more doses of the covid “vaccine” you’ve received, the more likely you are to suffer future infections, either by SARS-CoV-2 or other viruses, due to antibody-dependent enhancement.
Blood donations from people who have received several doses of mRNA injections may not provide adequate immunity against common infections, resulting in subclinical infections and diseases in recipients.
2. Formation of blood clots and amyloid aggregates – If the immune system of a blood recipient isn’t strong enough to neutralise spike protein, blood clots and amyloid aggregates may also form.
3. Chronic inflammation – Prolonged exposure to the antigens from the covid-19 injections can trigger the generation of IgG4 antibodies, resulting in chronic inflammation and immune dysfunction.
IgG4 antibodies are often associated with chronic exposure to antigens, such as those seen in persistent infections, certain cancers, and prolonged exposure to allergens. IgG4 antibodies are also associated with a unique condition known as IgG4-Related Disease (IgG4-RD), a fibro-inflammatory condition characterised by swellings or masses in affected organs.4
Blood Transfusions and the Risk of Autoimmune Diseases
The authors also raise concerns about the potential of contaminated blood to cause autoimmune diseases in recipients. Recent research found that the RNA pseudouridylation, a process in which uracil is swapped out for synthetic methylpseudouridine, can cause frameshifting, basically a glitch in the decoding, which can trigger the production of off-target aberrant proteins.
The antibodies that develop as a result may, in turn, trigger off-target immune reactions. In addition to that, lipid nanoparticles (“LNPs”), a key component of the covid injections, have been identified as highly inflammatory and possessing more potent adjuvant activity compared to traditional vaccine adjuvants, which further increases the risk of an autoimmune response. As reported in the featured paper:5
Recent studies have shown that RNA pseudouridylation can result in frameshifting. It is not yet clear whether a portion of the pseudouridinated mRNA for the spike protein is translated into another protein of unknown function in vaccine recipients. If these proteins are also pathogenic, additional testing for such frameshift proteins may be needed in the future.
Even if a frameshift protein is not toxic, it must be foreign to the body and could cause autoimmune disease. In addition, LNPs themselves are highly inflammatory substances … LNPs have been found to have stronger adjuvant activity than the adjuvants used in conventional vaccines, and there is also concern about autoimmune diseases resulting from this aspect.
Thus, although it is not clear what the causative agent of autoimmune disease is, the large number of reported cases of autoimmune disease following genetic vaccination is extremely concerning.
The very mechanism of gene vaccines that causes one’s own cells to produce the antigens of pathogens carries the risk of inducing autoimmune diseases, which cannot be completely avoided even if mRNA pseudouridylation technology is used.
In this context, individuals with a positive blood test for spike protein may need to have interviews and additional tests for autoimmune disease indicators, such as antinuclear antibodies.
Alternatively, if the amino acid sequence of the protein resulting from the frameshift is predictable, these candidate proteins could be included in the initial mass spectrometry assay. In any case, it is particularly important to develop tests and establish medical care settings in anticipation of these situations.
Proposals for Managing Blood Collection
The authors outline several specific proposals for managing blood collection and blood products from individuals who have received genetic “vaccines.” Given the variety of blood-related abnormalities observed post-injection, the researchers argue that rigorous and precautionary measures in blood handling and transfusion practices have now become a necessity.
A key part of the proposal involves conducting thorough interviews with potential blood donors. These interviews should cover their vaccination status, number of doses received, their covid-19 infection history, and any symptoms they might be experiencing that could indicate conditions like post-vaccination syndrome (“PVS”), long covid or other complications.
The researchers also recommend deferral periods for blood collected from covid injection recipients – 48 hours for mRNA shots and six weeks for AstraZeneca DNA jab recipients. A series of tests are also proposed to ensure the safety of collected blood, including:
Mass spectrometry to measure spike protein content
PCR for detecting the presence of spike protein mRNA and DNA
Testing for markers associated with autoimmune disorders
Enzyme-linked immunosorbent assay (ELISA)
Immunophenotyping
Liquid biopsies combined with proteomics to detect and quantify spike protein and its mRNA
The authors also note that policies and procedures must be constantly revised as new risks and problems with blood products derived from mRNA and DNA injection recipients are identified.
Ensuring Safety of Current Blood Products
The paper also reviews strategies to ensure the safety of blood products already collected, highlighting the complex challenges that medical institutions, regulatory bodies, and the broader healthcare ecosystem must navigate in the wake of the widespread use of mRNA injections.
The primary concern is the risk posed to patients by the use of blood products from donors who have received gene-based injections without confirming the presence or absence of spike proteins or modified mRNA. To ensure their safety, methods to quantify potential contaminants must be developed and implemented as soon as possible.
Another critical issue that must be addressed is the current lack of reliable methods to remove spike proteins or modified mRNA from blood products. The authors warn that, given the potential persistence, low solubility, heat resistance and radiation resistance of these components, current methodologies are inadequate for the job. The only solution, they say, is to discard all blood products found to contain these contaminants until effective removal techniques are established.
Researchers Call for Widespread Blood Testing
Additionally, the researchers call for widespread testing of both injected and non-injected to assess the potential transmission of spike proteins through exosomes (so-called shedding).
As noted by the authors:
… when exosomes collected from vaccine recipients were administered to mice that had not been vaccinated with the genetic vaccine, the spike protein was transmitted.
Therefore, it cannot be denied that the spike protein and its modified genes can be transmitted through exosomes. For this reason, we suggest that full testing be done initially, regardless of genetic vaccination status, and that a cohort study be conducted to quickly capture the full picture …
In addition … it cannot be ruled out that even those who have not been vaccinated with the genetic vaccine, but have had long covid, may have residual spike proteins or fibrin-derived microthrombi in their bodies, so it would be advisable to conduct the same testing and follow-up as for genetic vaccine recipients.
The presence or absence and amount of anti-nucleocapsid antibodies as well as antibody isotypes may be an indicator(s) in distinguishing whether genetic vaccination or long covid is the cause. In any case, these cohort studies are expected to help establish cutoff values for blood levels of spike protein and other substances to determine the safety of blood products.
Faksova et al. conducted a large cohort study of 99 million people using a multinational Global Vaccine Data NetworkTM (GVDN®) and found a significantly increased risk of myocarditis, pericarditis, Guillain-Barre syndrome and cerebral venous sinus thrombosis in genetic vaccine recipients.
Ensuring the traceability of blood products and establishing a rigorous legal and regulatory framework to manage the myriad issues arising from the use of blood products derived from covid-injected individuals are also paramount. This includes creating systems for the registration of all potential donors, ensuring the traceability of blood products and conducting recipient outcome studies.
Call to Pause: Evaluating the Risks and Benefits of Genetic Vaccines for a Safer Future
In conclusion, the authors point out that if we continue using mRNA-LPN-based platforms to replace conventional vaccines or create new ones, then the risks to our blood and bone marrow supply will be augmented further.
“The impact of these genetic vaccines on blood products and the actual damage caused by them are unknown at present,” they write.6
Therefore, in order to avoid these risks and prevent further expansion of blood contamination and complication of the situation, we strongly request that the vaccination campaign using genetic vaccines be suspendedand that a harm-benefit assessment be carried out as early as possible, as called for by Fraiman et al.7 and Polykretis et al.8
T]he health injuries caused by genetic vaccination are already extremely serious, and it is high time that countries and relevant organisations take concrete steps together to identify the risks and to control and resolve them.
Dr. Joseph Mercola is the founder and owner of Mercola.com, a Board-Certified Family Medicine Osteopathic Physician, a Fellow of the American College of Nutrition and a New York Times bestselling author. He publishes multiple articles a day covering a wide range of topics on his website Mercola.com.
_______________
Japan Ahead of the Curve
Japan appears to be ahead of the curve not only in showing the seriousness of the mRNA injection issues, but politically as well. Recently, Kazuhiro Haraguichi, former Japanese Minister for Internal Affairs has become the first major politician to apologize to the unvaccinated for the tsunami of deaths occurring among the ‘vaccinated.’ After getting two out of three COVID shots which were from ‘lethal’ batches, he developed a rapidly progressing form of cancer. Three of his colleagues were also severely affected, but they haven’t spoken out. He states those that do are censored. He has urged people to stand united in challenging the government.
Thelibertybeacon.com reports: One of the key points in Haraguchi’s speech was his criticism of the ban on Ivermectin, a drug developed by Dr. Satoshi Omura, which he believed could have played a significant role in combating the pandemic. Haraguchi questioned the motives behind the ban, suggesting that economic interests were prioritized over public health.
The Dangerous Dames Courtenay Turner & Dr Lee Merritt are joined by dangerous dude Adam Finnegan.
Adam is the author of “The Sleeper Agent”. He shares his personal medical journey that led him down the path of rigorous research and discovery. The conversation spans subjects of Lyme disease, history of bioweapons, the question of virology and what really makes us humans ill.
According to Finnegan, Lyme disease was not invented at the Plum Island lab in 1975, it was weaponized long before, around 1939 in Germany where Eric Traub conducted tests there with his weaponized strains. The actual spirochete, before it was weaponized, had been around for many years, and was a bird strain of Borrelia called Borrelia anserina,[2] and had several developments, but may have been weaponized once more during Traub’s return to the United States after WWII and conducted tests with it on Plum Island.
Regarding the findings in the five thousand year old mummy, scientists did NOT find Bb, or Ba, nor Bg – the three species of borrelia responsible for Lyme disease. They simply found traces of what they thought might be borrelia species but said further testing is needed to confirm this.
Madison Area Lyme Support Group 